(Other current news and archived releases from the Thomas Jefferson University Hospital are available.)

Kimmel Cancer Center at Jefferson Holds Clinical Translational Research Retreat

The Kimmel Cancer Center at Jefferson held a Clinical Translational Research Retreat on Saturday, December 9, 2006. The retreat was well attended by clinicians and basic scientists who discussed opportunities for translational research. Links to all of the presentations are available below.

 

 

 

Agenda

Opening Remarks and Program Overview, Richard G. Pestell, MD, PhD Director, Kimmel Cancer Center Walter J. Curran, Jr., MD Director of Clinical Science, KCC

Therapeutic Inhibition of Immune Escape in Cancer, George C. Prendergast, PhD Professor and President/CEO, Lankenau Institute for Medical Research

Immune Modulation of EGFT Targeted Therapy, Ulrich Rodeck, PhD Department of Dermatology

Pancreatic Tumor Profiling: Stratifying Patients for Rationale Therapy, Jonathan Brody, PhD Department of Surgery

Robotics Assisted interventions, Yan Yu, PhD, MBA Department of Radiation Oncology

Mass Spectrometry Based Approaches to Biomarker Discovery and Validation, Andrew Quong, PhD Department of Cancer Biology

Clinical Research Summary, Walter J. Curran, Jr., MD Director of Clinical Science, KCC